Speaker illustration

Professor John Wilding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Novel anti-obesity drugs - a paradigm shift for disease prevention?

Event: ESC Congress 2023

Topic: Obesity

Session: Novel weight loss strategies to reduce cardiovascular risk in obesity

Thumbnail

Panel discussion.

Event: ESC Congress 2020

Topic: Obesity

Session: Improving cardiovascular risk management in patients with obesity

Thumbnail

Impact of weight loss on cardiovascular risk.

Event: ESC Congress 2020

Topic: Obesity

Session: Improving cardiovascular risk management in patients with obesity

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb